SeniorJournal.com - Daily News for Senior Citizens

  FRONT PAGE Aging • Health • Alzheimer's - Mental • Nutrition • Medicare & Medicaid Politics  • Fitness  • Social Security • Alerts • Sex Health • Features • Retirement  Elder Care  >Search  >Senior Links

[NavBar.htm]

Senior Journal: Today's News and Information for Senior Citizens & Baby Boomers

More Senior Citizen News and Information Than Any Other Source - SeniorJournal.com

• Go to more on Health & Medicine or More Senior News from SeniorJournal.com on the Front Page

 
 
Follow on  and 

E-mail this page to a friend!

Health & Medicine for Senior Citizens

New Cancer Drug ZL105 Ten Times More Effective Fighting Some Cancers: Game-Changer

May be ten times more effective in treating ovarian, colon, melanoma, renal, and some breast cancers

Doctor examines chest x-ray checking for cancerMarch 26, 2014 - A game-changer in the battle against cancer may just be a new drug called ZL105, which researchers say can manipulate the body’s natural signalling and energy systems, allowing the body to attack and shut down cancerous cells. They foresee a revolution in cancer treatment that may lead to a dramatic improvement in cancer survival rates.

Preliminary data indicate that the novel drug may be ten times more effective in treating ovarian, colon, melanoma, renal, and some breast cancers, according to data obtained by the U.S. National Cancer Institute.

ZL105 is a compound based on the precious metal iridium, according to the study from the University of Warwick, Coventry, U.K., which is published today in the journal Angewandte Chemie International Edition.

The study has found ZL105 could potentially replace currently used anticancer drugs, which become less effective over time, cause a wide-range of side-effects and damage healthy cells as well as cancerous.

 

Related Archive Stories

 
 

Obese Women See Uterine Cancer Risk Reduced Over 70 Percent After Bariatric Surgery

May not be senior age limit for surgery or Medicare coverage if all other criteria met

March 22, 2014

Physical Activity Reduces Breast Cancer Risk at Any Age Says Study of Four Million Women

Age, nor size, nor geographical location alters the benefits of physical exercise

March 20, 2014

Colon Cancer Rate Takes Big Drop, Particularly for Senior Citizens

Larger declines among Medicare-eligible seniors likely reflect higher rates of screening because of universal insurance coverage

March 17, 2014


 
 

Read the latest news
> Health & Medicine
>
Today's Headlines

 

Commenting on the breakthrough, University of Warwick researcher and study co-author Dr. Isolda Romero-Canelon said “The energy-producing machinery in cancer cells works to the limit as it attempts to keep up with quick proliferation and invasion. This makes cancer cells susceptible to minor changes in the cell ‘power-house’.

“Our drug pushes cancer cells over the limit causing them to slow and shut down, whilst normal cells can cope with its effects.”

The researchers now aim to expand the study to cancers that are inherently resistant to existing drugs and to those which have developed resistance after a first round of chemotherapy treatments.

Study co-author Professor Peter J. Sadler said “Existing cancer treatments often become less effective after the first course, as cancer cells learn how they are being attacked. The drug we have developed is a catalyst and is active at low doses. It can attack cancer cells in multiple ways at the same time, so the cancer is less able to adapt to the treatment. This means the new drugs could be much more effective than existing treatments.”

“Platinum-based drugs are used in nearly 50% of all chemotherapeutic regimens, exert their activity by damaging DNA and cannot select between cancerous and non-cancerous cells, leading to a wide-range of side-effects from renal failure to neurotoxicity, ototoxicity, nausea and vomiting.

“In contrast, the new iridium-based drug is specifically designed not to attack DNA, but to have a novel mechanism of action, meaning that it could not only dramatically slow down and halt cancer growth, but also significantly reduce the side effects suffered by patients” argues Professor Sadler.

This research could also lead to substantial improvements in cancer survival rates.

“Current statistics indicate that one in every three people will develop some kind of cancer during their life time, moreover approximately one woman dies of ovarian cancer every two hours in the UK according to Cancer Research UK. It is clear that a new generation of drugs is necessary to save more lives and our research points to a highly effective way of defeating cancerous cells” said Dr. Romero-Canelon.

About the University of Warwick

 

Financial Relief for Volkswagen Diesel Owners

You may be eligible for money damages if you owned or leased one of these VW, Porsche or Audi vehicles.

In the major scandal of 2015, Volkswagen cheated you and the world. They rigged diesel emission controls so you, nor regulators, would know how much pollution their cars were adding to our environment.

They were caught and have reserved $7.3 billion to help "make it right" with victims.

If you owned or leased one of these vehicles, contact us now.

 Beth Janicek, Board Certified Personal Injury Attorney Janicek Law attorneys are actively pursuing these cases against VW. Do Not Wait...

Janicek Law Firm, PC

Free Consultation

(Call toll free)

1-877-795-3425 or Email

Vehicles Involved

VW Jetta (2009–2015)

VW Jetta SportWagen (2009–2014)

VW Golf (2010-2015)

VW Golf SportWagen (2015)

VW Beetle (2012–2015)

VW Passat (2012-2015)

Audi A3 (2010-2015)

VW Touareg (2009–2016)

Porsche Cayenne (2015)

Audi A6, A7, A8, Q5 Quattro (2016)

 

Search for more about this topic on SeniorJournal.com

Google Web SeniorJournal.com

Keep up with the latest news for senior citizens, baby boomers

 

Click to More Senior News on the Front Page

Copyright: SeniorJournal.com

    

 

Published by New Tech Media - www.NewTechMedia.com

Other New Tech Media sites include CaroleSutherland.com, BethJanicek.com, SASeniors.com, DrugDanger.com, etc.